BlackRock Health Sciences Term Trust (NYSE:BMEZ) Plans Monthly Dividend of $0.11

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, February 27th. Investors of record on Monday, June 15th will be paid a dividend of 0.11 per share on Tuesday, June 30th. This represents a c) annualized dividend and a yield of 9.1%. The ex-dividend date of this dividend is Monday, June 15th.

BlackRock Health Sciences Term Trust Trading Up 0.6%

BMEZ stock opened at $14.52 on Friday. BlackRock Health Sciences Term Trust has a 12 month low of $13.67 and a 12 month high of $15.80. The firm has a 50-day moving average of $14.29 and a two-hundred day moving average of $14.74.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

A number of large investors have recently made changes to their positions in BMEZ. Rivernorth Capital Management LLC lifted its position in BlackRock Health Sciences Term Trust by 24.8% during the first quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after buying an additional 160,629 shares in the last quarter. Saba Capital Management L.P. acquired a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth $10,907,000. Lazard Asset Management LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 64.2% during the 1st quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock worth $8,926,000 after acquiring an additional 243,054 shares during the period. Quantedge Capital Pte Ltd boosted its position in shares of BlackRock Health Sciences Term Trust by 85.0% during the 1st quarter. Quantedge Capital Pte Ltd now owns 135,854 shares of the company’s stock valued at $1,951,000 after acquiring an additional 62,400 shares during the last quarter. Finally, PNC Financial Services Group Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter valued at about $35,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.